Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore

Current Cancer Drug Targets

  • h-index: 111
  • Total citations: 61,196
  • Total papers: 1,667
  • Impact factor: 2.56

Homepage: http://www.benthamscience.com/ccdt/index.htm

Current Cancer Drug Targets

Journal
Visit website →
H-Index = 111
Citations = 61.20K+

Papers

Evidence

Recent papers in Current Cancer Drug Targets

  1. Therapy-Induced Cellular Senescence in Non-Hodgkin Lymphomas, with Emphasis on Aggressive B-Cell Subtypes: Molecular Mechanisms and Emerging Drug TargetsCurrent Cancer Drug Targets · Tue,
  2. Comprehensive Immune Subtyping and Multi-Omics Profiling of the Tumor Microenvironment in Colorectal Cancer: Implications for Prognosis and Personalized ImmunotherapyCurrent Cancer Drug Targets · Fri,
  3. Integrated Computational and Experimental Discovery of a Promising Xanthine Derivative with Anticancer Potential Targeting EGFRCurrent Cancer Drug Targets · Wed,
  4. Identification of the Immune Microenvironment, Mutation Burden, Immunotherapy, and Drug Sensitivity Related to Lung Adenocarcinoma Tumor Stem Cells via WGCNACurrent Cancer Drug Targets · Fri,
  5. Multi-omics Approaches to CCAAT/Enhancer-Binding Protein Beta in Oral Squamous Cell Carcinoma: Crosstalk Between Tumor Cells and Tumor-Associated Macrophages Driving Disease ProgressionCurrent Cancer Drug Targets · Thu,
  6. Lipidomic Profiling in Cancer: Phospholipid Alterations and their Role in Tumor ProgressionCurrent Cancer Drug Targets · Thu,
  7. Grafting of Resveratrol-Chitosan Nanoparticles as a Promising Radiosensitizer and Protector in DMBA-Induced Breast Cancer in MiceCurrent Cancer Drug Targets · Fri,
  8. Driver Genes and Genomic Instability Predict the Incidence and Outcome of Brain MetastasesCurrent Cancer Drug Targets · Wed,
  9. Single-Cell Transcriptomics: Technical Advances, Applications and Challenges in Cancer Drug DiscoveryCurrent Cancer Drug Targets · Wed,
  10. SOX9 Promotes Breast Cancer Progression via the EGFR/STAT3 Signaling AxisCurrent Cancer Drug Targets · Fri,

About Current Cancer Drug Targets

Current Cancer Drug Targets carries 1,667 indexed papers, 61,196 citations, h-index 111 in Synapse's enriched corpus. Each paper indexed here includes structured clinical evidence extraction (PICO), methodology classification with level of evidence, and links to related guideline recommendations where applicable.

On Synapse's credibility score (derived from SJR ranking and cross-citation patterns), Current Cancer Drug Targets sits among the highest-credibility cardiovascular journals.

The journal's official homepage is at http://www.benthamscience.com/ccdt/index.htm.

Use the feed below to follow new Current Cancer Drug Targets publications with AI-enriched analysis — each paper is decomposed into study design, population, intervention, comparator, primary outcome, and key finding, with the underlying evidence traceable to the primary source.

Deterministic synthesis from Synapse's enriched records — 108 words.